Cargando…
Intergrated analysis of ELMO1, serves as a link between tumour mutation burden and epithelial-mesenchymal transition in hepatocellular carcinoma
BACKGROUND: Epithelial-mesenchymal transition (EMT) is critical for cancer cell metastasis. Recently, EMT was reported to be associated with the inflammatory tumour microenvironment and, therefore, might be a predictive biomarker for immune checkpoint blockade agents. However, the underlying mechani...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710851/ https://www.ncbi.nlm.nih.gov/pubmed/31324602 http://dx.doi.org/10.1016/j.ebiom.2019.07.002 |
_version_ | 1783446422651142144 |
---|---|
author | Peng, Hong Zhang, Yi Zhou, Zhiwei Guo, Yu Huang, Xiaohui Westover, Kenneth D. Zhang, Zhaohui Chen, Bin Hua, Yunpeng Li, Shaoqiang Xu, Ruiyun Lin, Nan Peng, Baogang Shen, Shunli |
author_facet | Peng, Hong Zhang, Yi Zhou, Zhiwei Guo, Yu Huang, Xiaohui Westover, Kenneth D. Zhang, Zhaohui Chen, Bin Hua, Yunpeng Li, Shaoqiang Xu, Ruiyun Lin, Nan Peng, Baogang Shen, Shunli |
author_sort | Peng, Hong |
collection | PubMed |
description | BACKGROUND: Epithelial-mesenchymal transition (EMT) is critical for cancer cell metastasis. Recently, EMT was reported to be associated with the inflammatory tumour microenvironment and, therefore, might be a predictive biomarker for immune checkpoint blockade agents. However, the underlying mechanism is still unclear. METHODS: Patient survival data for our HCC cohort, TCGA and GEO datasets were determined by Kaplan-Meier analysis. The functional roles of ELMO1 in HCC were demonstrated by a series of in vitro and in vivo experiments. Gene microarray analysis was used to demonstrate potential mechanisms of ELMO1. Data retrieved from the TCGA datasets were used to determine the relationships of ELMO1, EMT and TMB. FINDINGS: Here, we report an indispensable role for ELMO1 in linking EMT with tumour mutation burden (TMB), which is a promising biomarker for the immune checkpoint blockade agent response. Upregulated ELMO1 expression is associated with a poor prognosis in hepatocellular carcinoma (HCC), as well as increased cell growth, invasion, migration, angiogenesis and EMT in vitro and in vivo. Mechanistically, we provide evidence that ELMO1 regulates SOX10 expression and induces EMT through PI3K/Akt signalling. Moreover, ELMO1 is negatively associated with TMB, indicating a negative relationship between EMT and TMB. INTERPRETATION: ELMO1 serves as a link between EMT and TMB, providing a mechanistic basis for the further development of ELMO1 as a therapeutic target against HCC and potentially a promising biomarker of the immune checkpoint blockade agent response. FUND: National Natural Science Foundation of China; Natural Science Foundation of Guangdong Province; Young Teacher Training Program of Sun Yat-sen University; Science and Technology Plan of Guangdong Province; Special Support Program of Guangdong Province, Science and Technology Innovation Youth Talent Support Program; the Pearl River Science and Technology New Talent of Guangzhou City; Medical Scientific Research Foundation of Guangdong Province. |
format | Online Article Text |
id | pubmed-6710851 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-67108512019-08-29 Intergrated analysis of ELMO1, serves as a link between tumour mutation burden and epithelial-mesenchymal transition in hepatocellular carcinoma Peng, Hong Zhang, Yi Zhou, Zhiwei Guo, Yu Huang, Xiaohui Westover, Kenneth D. Zhang, Zhaohui Chen, Bin Hua, Yunpeng Li, Shaoqiang Xu, Ruiyun Lin, Nan Peng, Baogang Shen, Shunli EBioMedicine Research paper BACKGROUND: Epithelial-mesenchymal transition (EMT) is critical for cancer cell metastasis. Recently, EMT was reported to be associated with the inflammatory tumour microenvironment and, therefore, might be a predictive biomarker for immune checkpoint blockade agents. However, the underlying mechanism is still unclear. METHODS: Patient survival data for our HCC cohort, TCGA and GEO datasets were determined by Kaplan-Meier analysis. The functional roles of ELMO1 in HCC were demonstrated by a series of in vitro and in vivo experiments. Gene microarray analysis was used to demonstrate potential mechanisms of ELMO1. Data retrieved from the TCGA datasets were used to determine the relationships of ELMO1, EMT and TMB. FINDINGS: Here, we report an indispensable role for ELMO1 in linking EMT with tumour mutation burden (TMB), which is a promising biomarker for the immune checkpoint blockade agent response. Upregulated ELMO1 expression is associated with a poor prognosis in hepatocellular carcinoma (HCC), as well as increased cell growth, invasion, migration, angiogenesis and EMT in vitro and in vivo. Mechanistically, we provide evidence that ELMO1 regulates SOX10 expression and induces EMT through PI3K/Akt signalling. Moreover, ELMO1 is negatively associated with TMB, indicating a negative relationship between EMT and TMB. INTERPRETATION: ELMO1 serves as a link between EMT and TMB, providing a mechanistic basis for the further development of ELMO1 as a therapeutic target against HCC and potentially a promising biomarker of the immune checkpoint blockade agent response. FUND: National Natural Science Foundation of China; Natural Science Foundation of Guangdong Province; Young Teacher Training Program of Sun Yat-sen University; Science and Technology Plan of Guangdong Province; Special Support Program of Guangdong Province, Science and Technology Innovation Youth Talent Support Program; the Pearl River Science and Technology New Talent of Guangzhou City; Medical Scientific Research Foundation of Guangdong Province. Elsevier 2019-07-16 /pmc/articles/PMC6710851/ /pubmed/31324602 http://dx.doi.org/10.1016/j.ebiom.2019.07.002 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research paper Peng, Hong Zhang, Yi Zhou, Zhiwei Guo, Yu Huang, Xiaohui Westover, Kenneth D. Zhang, Zhaohui Chen, Bin Hua, Yunpeng Li, Shaoqiang Xu, Ruiyun Lin, Nan Peng, Baogang Shen, Shunli Intergrated analysis of ELMO1, serves as a link between tumour mutation burden and epithelial-mesenchymal transition in hepatocellular carcinoma |
title | Intergrated analysis of ELMO1, serves as a link between tumour mutation burden and epithelial-mesenchymal transition in hepatocellular carcinoma |
title_full | Intergrated analysis of ELMO1, serves as a link between tumour mutation burden and epithelial-mesenchymal transition in hepatocellular carcinoma |
title_fullStr | Intergrated analysis of ELMO1, serves as a link between tumour mutation burden and epithelial-mesenchymal transition in hepatocellular carcinoma |
title_full_unstemmed | Intergrated analysis of ELMO1, serves as a link between tumour mutation burden and epithelial-mesenchymal transition in hepatocellular carcinoma |
title_short | Intergrated analysis of ELMO1, serves as a link between tumour mutation burden and epithelial-mesenchymal transition in hepatocellular carcinoma |
title_sort | intergrated analysis of elmo1, serves as a link between tumour mutation burden and epithelial-mesenchymal transition in hepatocellular carcinoma |
topic | Research paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710851/ https://www.ncbi.nlm.nih.gov/pubmed/31324602 http://dx.doi.org/10.1016/j.ebiom.2019.07.002 |
work_keys_str_mv | AT penghong intergratedanalysisofelmo1servesasalinkbetweentumourmutationburdenandepithelialmesenchymaltransitioninhepatocellularcarcinoma AT zhangyi intergratedanalysisofelmo1servesasalinkbetweentumourmutationburdenandepithelialmesenchymaltransitioninhepatocellularcarcinoma AT zhouzhiwei intergratedanalysisofelmo1servesasalinkbetweentumourmutationburdenandepithelialmesenchymaltransitioninhepatocellularcarcinoma AT guoyu intergratedanalysisofelmo1servesasalinkbetweentumourmutationburdenandepithelialmesenchymaltransitioninhepatocellularcarcinoma AT huangxiaohui intergratedanalysisofelmo1servesasalinkbetweentumourmutationburdenandepithelialmesenchymaltransitioninhepatocellularcarcinoma AT westoverkennethd intergratedanalysisofelmo1servesasalinkbetweentumourmutationburdenandepithelialmesenchymaltransitioninhepatocellularcarcinoma AT zhangzhaohui intergratedanalysisofelmo1servesasalinkbetweentumourmutationburdenandepithelialmesenchymaltransitioninhepatocellularcarcinoma AT chenbin intergratedanalysisofelmo1servesasalinkbetweentumourmutationburdenandepithelialmesenchymaltransitioninhepatocellularcarcinoma AT huayunpeng intergratedanalysisofelmo1servesasalinkbetweentumourmutationburdenandepithelialmesenchymaltransitioninhepatocellularcarcinoma AT lishaoqiang intergratedanalysisofelmo1servesasalinkbetweentumourmutationburdenandepithelialmesenchymaltransitioninhepatocellularcarcinoma AT xuruiyun intergratedanalysisofelmo1servesasalinkbetweentumourmutationburdenandepithelialmesenchymaltransitioninhepatocellularcarcinoma AT linnan intergratedanalysisofelmo1servesasalinkbetweentumourmutationburdenandepithelialmesenchymaltransitioninhepatocellularcarcinoma AT pengbaogang intergratedanalysisofelmo1servesasalinkbetweentumourmutationburdenandepithelialmesenchymaltransitioninhepatocellularcarcinoma AT shenshunli intergratedanalysisofelmo1servesasalinkbetweentumourmutationburdenandepithelialmesenchymaltransitioninhepatocellularcarcinoma |